Cas:1227732-30-0 methyl 2-acetamido-3-(3-thienyl)propanoate manufacturer & supplier

Chemical Name:methyl 2-acetamido-3-(3-thienyl)propanoate

CAS.NO:1227732-30-0

Synonyms:methyl 2-acetamido-3-(3-thienyl)propanoate

Molecular Formula:C₁₀H₁₃NO₃S

Molecular Weight:227.28000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:83.64000

Exact Mass:227.06200

LogP:1.35920

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like methyl 2-acetamido-3-(3-thienyl)propanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 2-acetamido-3-(3-thienyl)propanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 2-acetamido-3-(3-thienyl)propanoate Use and application,methyl 2-acetamido-3-(3-thienyl)propanoate technical grade,usp/ep/jp grade.

Related News: The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. methyl 2-acetamido-3-(3-thienyl)propanoate manufacturer While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. methyl 2-acetamido-3-(3-thienyl)propanoate supplier The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. methyl 2-acetamido-3-(3-thienyl)propanoate vendor The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. methyl 2-acetamido-3-(3-thienyl)propanoate factory Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report.